schizophrenia
Conditions
Interventions
None listed
Sponsors
The Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients between the ages of 20 and 80 2)Patients receiving treatment at the outpatient department of neuropsychiatry, The Jikei University School of Medicine, Tokyo, Japan, or the Katsushika Medical Center, Tokyo Jikei University School of Medicine 3) Patients diagnosed with schizophrenia on the DSM-IV-TR 4) Patients taking the antipsychotic drug asenapine (SYCREST) 5) Patients who can read and understand the Notice of Consent Explanation.
Exclusion criteria
Exclusion criteria: 1) Patients with schizophrenia who have significant hallucinatory delusions and significant behavioralization. 2) Patients with poor judgment due to psychiatric symptoms such as depressed mood, anxiety, agitation, elated mood, and aggression, who have difficulty participating in the study voluntarily. 3) Patients who are deemed inappropriate by the attending physician or physician in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in taste tendencies between those who continued to take asenapine and those who dropped out. Identification of taste trends that predict asenapine dropout. | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in preference for additional flavors between those who continue to take asenapine and those who drop out | — |
Countries
Japan
Contacts
Public ContactFumitoshi Kodaka
The Jikei University School of Medicine Department of Psychiatry
Outcome results
None listed